BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - FRA:BAYN - DE000BAY0017 - Common Stock
28.37 EUR
-1.56 (-5.23%)
Taking everything into account, BAYN scores 3 out of 10 in our fundamental rating. BAYN was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of BAYN have multiple concerns. BAYN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BAYN had positive earnings in the past year.
In the past year BAYN had a positive cash flow from operations.
In multiple years BAYN reported negative net income over the last 5 years.
Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BAYN (-3.25%) is worse than 64.81% of its industry peers.
With a Return On Equity value of -11.25%, BAYN is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of BAYN has declined.
BAYN's Gross Margin of 54.95% is on the low side compared to the rest of the industry. BAYN is outperformed by 68.52% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
The Profit Margin and Operating Margin are not available for BAYN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BAYN has about the same amout of shares outstanding than it did 1 year ago.
BAYN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BAYN has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.81, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.81, BAYN is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
The Debt to FCF ratio of BAYN is 8.37, which is on the high side as it means it would take BAYN, 8.37 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.37, BAYN is doing worse than 64.81% of the companies in the same industry.
A Debt/Equity ratio of 1.04 is on the high side and indicates that BAYN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.04, BAYN is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.81 |
ROIC/WACCN/A
WACC6.52%
2.3 Liquidity
A Current Ratio of 1.13 indicates that BAYN should not have too much problems paying its short term obligations.
BAYN has a Current ratio of 1.13. This is in the lower half of the industry: BAYN underperforms 66.67% of its industry peers.
BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
BAYN has a worse Quick ratio (0.73) than 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The earnings per share for BAYN have decreased strongly by -15.95% in the last year.
BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
BAYN shows a decrease in Revenue. In the last year, the revenue decreased by -2.16%.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-15.95%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-38.78%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-2.09%
3.2 Future
Based on estimates for the next years, BAYN will show a small growth in Earnings Per Share. The EPS will grow by 3.36% on average per year.
The Revenue is expected to grow by 1.49% on average over the next years.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 5.77 indicates a rather cheap valuation of BAYN.
Based on the Price/Earnings ratio, BAYN is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.91. BAYN is valued rather cheaply when compared to this.
BAYN is valuated cheaply with a Price/Forward Earnings ratio of 5.82.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 96.30% of the companies listed in the same industry.
BAYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.77 | ||
| Fwd PE | 5.82 |
4.2 Price Multiples
74.07% of the companies in the same industry are more expensive than BAYN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BAYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.07 | ||
| EV/EBITDA | 9.27 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, BAYN is not a good candidate for dividend investing.
BAYN's Dividend Yield is comparable with the industry average which is at 2.89.
With a Dividend Yield of 0.41, BAYN pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
BAYN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.69%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
FRA:BAYN (11/14/2025, 2:32:48 PM)
28.37
-1.56 (-5.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.87B
Revenue(TTM)46.61B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.07 (2.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)-0.08%
PT rev (3m)0.59%
EPS NQ rev (1m)-5.7%
EPS NQ rev (3m)-8.54%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.77 | ||
| Fwd PE | 5.82 | ||
| P/S | 0.6 | ||
| P/FCF | 6.07 | ||
| P/OCF | 3.9 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.27 |
EPS(TTM)4.92
EY17.34%
EPS(NY)4.87
Fwd EY17.18%
FCF(TTM)4.67
FCFY16.48%
OCF(TTM)7.28
OCFY25.65%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.81 |
F-Score4
WACC6.52%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.95%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-38.78%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-2.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.12%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.69%.